In this blog interview, Jacques Bernier discusses the future of medicine at Campus Genolier, emphasizing the role of genomics, AI, and personalized therapies. He highlights the campus's focus on precision medicine and international collaboration, along with the importance of training healthcare professionals to adapt to technological advancements.
The future of medicine will be marked by greater personalisation of treatments, thanks to the rise of technologies such as artificial intelligence, genomics and targeted therapies. The Campus Genolier will play a central role in integrating these innovations into diagnostic procedures and care, accelerating translational research and becoming a centre of excellence for precision medicine in both biomolecular sciences and medtech. Thanks to the efforts it is making and will continue to make in the field of translational research, the campus will increasingly become an innovation hub, facilitating the rapid implementation of scientific discoveries.
Future trends will include, for example, the increasing use of precision medicine, AI for diagnostics and vaccinology, areas where the Campus Genolier will be at the forefront of research and clinical application. With this in mind, joint projects inviting industrial partners to share knowledge and accelerate medical discoveries have already borne fruit. This is the case, on our Campus, of recent co-creations in the fields of radio-oncology and nuclear medicine (theranostics) by Accuray, Raysearch and General Electric Innovation.
For many years, we have pursued a clear strategy in this area: that of partnership. The campus works actively with national and international research institutes, such as the SITEM Start Up Club in Bern and the European Institute of Oncology in Milan, to name but two. Discussions at the highest levels with the authorities of the Swiss Federal Institutes of Technology in Lausanne and Zurich are underway, with a growing focus on the healthcare sector. Not to mention concerted action with industrial partners to share knowledge and accelerate medical discoveries at a global level. These partnerships strengthen the campus' position in collaborative research and training initiatives. All of this comes together in the Genolier Innovation Network, the network we recently created by bringing together the partners of the Genolier Innovation Hub and the Swiss Medical Network.